NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 207 filers reported holding NEKTAR THERAPEUTICS in Q1 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $560,000 | -24.6% | 28,619 | -9.6% | 0.02% | -23.8% |
| Q1 2017 | $743,000 | +67.0% | 31,649 | -12.7% | 0.02% | +61.5% |
| Q4 2016 | $445,000 | -46.2% | 36,269 | -24.7% | 0.01% | -45.8% |
| Q3 2016 | $827,000 | +19.3% | 48,139 | -1.1% | 0.02% | +14.3% |
| Q2 2016 | $693,000 | +13.4% | 48,679 | +9.5% | 0.02% | +16.7% |
| Q1 2016 | $611,000 | -22.1% | 44,439 | -4.5% | 0.02% | -21.7% |
| Q4 2015 | $784,000 | +42.8% | 46,509 | -7.1% | 0.02% | +35.3% |
| Q3 2015 | $549,000 | +300.7% | 50,079 | +282.0% | 0.02% | +466.7% |
| Q3 2013 | $137,000 | -9.9% | 13,109 | -0.7% | 0.00% | -25.0% |
| Q2 2013 | $152,000 | – | 13,199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |